Health Catalyst, Inc.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenue:
Total cost of revenue, excluding depreciation and amortization $43.6m $59.9m $75.3m $98.1m $124.4m $143.0m $164.1m $165.8m $159.5m
Research and development $28.5m $38.6m $46.3m $53.5m $62.7m $75.7m $72.6m $58.0m $49.8m
Total operating expenses $75.0m $112.8m $134.5m $186.9m $261.2m $273.2m $258.7m $210.6m $312.5m
Sales and marketing $25.9m $44.1m $47.3m $55.4m $75.0m $87.5m $67.3m $54.4m $52.5m
General and administrative $14.7m $22.7m $31.7m $59.2m $85.9m $61.7m $76.6m $56.8m $49.6m
Depreciation and amortization $5.9m $7.4m $9.2m $18.7m $37.5m $48.3m $42.2m $41.4m $50.5m
Impairment of goodwill and intangible assets $0 $0 $110.2m
Loss from operations ($45.5m) ($60.1m) ($54.9m) ($96.1m) ($143.7m) ($140.0m) ($126.9m) ($69.8m) ($160.9m)
Loss before income taxes ($47.0m) ($62.1m) ($60.0m) ($116.2m) ($160.1m) ($141.7m) ($117.8m) ($69.2m) ($177.3m)
Income tax provision $26k ($135k) $142k ($1.2m) ($6.9m) ($4.3m) $356k $333k $716k
Net loss ($47.0m) ($62.0m) ($60.1m) ($115.0m) ($153.2m) ($137.4m) ($118.1m) ($69.5m) ($178.0m)
Net loss per share, basic (in USD per share) ($13) ($3) ($3) ($3) ($2) ($1) ($3)
Net loss per share, diluted (in USD per share) ($13) ($3) ($3) ($3) ($2) ($1) ($3)
Weighted-average shares outstanding used in calculating net loss per share, basic (in shares) (3) (3) (3) (3) (2) (1) (3)
Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares) (3) (3) (3) (3) (2) (1) (3)
Interest and other (expense) income, net ($1.7m) $9.1m $637k ($16.4m)